WO2008127298A3 - Staphylococcal enterotoxin b peptide compositions and methods of use - Google Patents
Staphylococcal enterotoxin b peptide compositions and methods of use Download PDFInfo
- Publication number
- WO2008127298A3 WO2008127298A3 PCT/US2007/022473 US2007022473W WO2008127298A3 WO 2008127298 A3 WO2008127298 A3 WO 2008127298A3 US 2007022473 W US2007022473 W US 2007022473W WO 2008127298 A3 WO2008127298 A3 WO 2008127298A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- peptide compositions
- staphylococcal enterotoxin
- peptides
- seb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/05—Adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to bacterial peptides, specifically Staphylococcus Enterotoxin B (SEB) peptides that have therapeutic use. The invention further relates to the use of SEB peptides in the diagnosis and therapy of diseases associated with cell proliferation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85390606P | 2006-10-24 | 2006-10-24 | |
US60/853,906 | 2006-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008127298A2 WO2008127298A2 (en) | 2008-10-23 |
WO2008127298A3 true WO2008127298A3 (en) | 2009-05-22 |
Family
ID=39864508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/022473 WO2008127298A2 (en) | 2006-10-24 | 2007-10-24 | Staphylococcal enterotoxin b peptide compositions and methods of use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008127298A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021121277A1 (en) * | 2019-12-16 | 2021-06-24 | Tuan Mei Nan | A method and composition for treatment of a cancer |
JP2024509911A (en) * | 2021-03-11 | 2024-03-05 | ザ メソディスト ホスピタル | Methods and compositions for the treatment of diseases |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030147908A1 (en) * | 1996-12-30 | 2003-08-07 | Raymond Kaempfer | Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins |
US20030152652A1 (en) * | 2000-05-05 | 2003-08-14 | Baker John D. | Use of echinacea as a hematinic agent |
US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
US20040072857A1 (en) * | 2002-07-02 | 2004-04-15 | Jacob Waugh | Polymerized and modified rapamycins and their use in coating medical prostheses |
US20050089958A1 (en) * | 1996-01-09 | 2005-04-28 | Genentech, Inc. | Apo-2 ligand |
US20060204565A1 (en) * | 2003-05-06 | 2006-09-14 | Low Philip S | Conjugates and use thereof |
US20060229255A1 (en) * | 2003-04-15 | 2006-10-12 | Gema Tarrason | Identification of n-alkylglycine trimers for induction of apoptosis |
-
2007
- 2007-10-24 WO PCT/US2007/022473 patent/WO2008127298A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089958A1 (en) * | 1996-01-09 | 2005-04-28 | Genentech, Inc. | Apo-2 ligand |
US20030147908A1 (en) * | 1996-12-30 | 2003-08-07 | Raymond Kaempfer | Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins |
US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
US20030152652A1 (en) * | 2000-05-05 | 2003-08-14 | Baker John D. | Use of echinacea as a hematinic agent |
US20040072857A1 (en) * | 2002-07-02 | 2004-04-15 | Jacob Waugh | Polymerized and modified rapamycins and their use in coating medical prostheses |
US20060229255A1 (en) * | 2003-04-15 | 2006-10-12 | Gema Tarrason | Identification of n-alkylglycine trimers for induction of apoptosis |
US20060204565A1 (en) * | 2003-05-06 | 2006-09-14 | Low Philip S | Conjugates and use thereof |
Non-Patent Citations (8)
Also Published As
Publication number | Publication date |
---|---|
WO2008127298A2 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500644A1 (en) | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections | |
WO2010036876A3 (en) | Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota | |
WO2008053444A3 (en) | Treating a respiratory condition with bifidobacterium | |
WO2011143624A3 (en) | Humanized and chimeric monoclonal antibodies to cd47 | |
WO2007009894A3 (en) | Peptides for use in the treatment of obesity | |
WO2005103084A3 (en) | Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof | |
NZ618571A (en) | Peptides and their use | |
WO2008014200A3 (en) | Cyclosporin compositions | |
WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
WO2011008092A3 (en) | Gram-positive bacteria specific binding compounds | |
WO2007019865A3 (en) | Therapy with cd4 binding peptides and radiation | |
WO2011048390A3 (en) | Gadd45beta targeting agents | |
NZ598524A (en) | Therapeutic dll4 binding proteins | |
EP3461844A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders | |
WO2009044273A3 (en) | Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response | |
WO2007141274A3 (en) | Human binding molecules having killing activity against staphylococci and uses thereof | |
EP2759302A3 (en) | 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour | |
WO2010132370A3 (en) | Soluble tlt-1 for the treatment and diagnosis of sepsis | |
WO2008036929A3 (en) | Complex for transferring an anionic substance into a cell | |
WO2009099467A3 (en) | Cyclosporin compositions | |
WO2012083302A3 (en) | Compositions and methods for the treatment or prevention of human adenovirus-36 infection | |
WO2008093058A3 (en) | Peptides and their use | |
WO2012014214A3 (en) | Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension | |
WO2007144057A3 (en) | Antimicrobial carbon | |
WO2009062576A8 (en) | Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07873456 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07873456 Country of ref document: EP Kind code of ref document: A2 |